难治性滋养细胞肿瘤的治疗

苏 昊, 冯凤芝

中国实用妇科与产科杂志 ›› 2022, Vol. 38 ›› Issue (5) : 511-514.

中国实用妇科与产科杂志 ›› 2022, Vol. 38 ›› Issue (5) : 511-514. DOI: 10.19538/j.fk2022050109
专题笔谈

难治性滋养细胞肿瘤的治疗

作者信息 +

Management of refractory trophoblastic neoplasia.

Author information +
文章历史 +

摘要

难治性妊娠滋养细胞肿瘤再次治疗前,需要对疾病程度进行重新评估。多药联合挽救化疗仍是目前主要的治疗手段。对于病灶可切除干净的患者,同时联合手术治疗至关重要。此外,新兴的免疫治疗,给这些难治患者亦提供了新的治疗选择。治疗缓解后,需长期规律监测血人绒毛膜促性腺激素。

Abstract

All patients with refractory gestational trophoblastic neoplasia (GTN) require re-assessment of the extent of disease before initiating another treatment. Salvage chemotherapy with multiagent combination is still the main treatment option at present. For the patients with resectable lesions,it is crucial to perform a complete surgical excision of tumors simultaneously during salvage chemotherapy. In addition,these patients may also benefit from the emerging immunotherapy. After remission is achieved,serum human chorionic gonadotrophin (hCG) should be monitored regularly in a long term.

关键词

妊娠滋养细胞肿瘤 / 难治 / 化疗 / 手术治疗 / 免疫治疗

Key words

gestational trophoblastic neoplasia / refractory / chemotherapy / surgery / immunotherapy

引用本文

导出引用
苏 昊, 冯凤芝. 难治性滋养细胞肿瘤的治疗[J]. 中国实用妇科与产科杂志. 2022, 38(5): 511-514 https://doi.org/10.19538/j.fk2022050109
SU Hao, FENG Feng-zhi. Management of refractory trophoblastic neoplasia.[J]. Chinese Journal of Practical Gynecology and Obstetrics. 2022, 38(5): 511-514 https://doi.org/10.19538/j.fk2022050109
中图分类号: R737.3   

Accesses

Citation

Detail

段落导航
相关文章

/